DSM appoints new executive vp corporate strategy & acquisitions
Eykerman will succeed Hein Schreuder who will retire from the company on at the end of December after 20 years at DSM. DSM says Hein has played a key role in the transformation of the company as well as in the acquisitions and divestments of the company over the last 15 years.
With a track record of strategy development and M&A strategy and integration, DSM says Eykerman is well positioned to lead the company’s corporate strategy and acquisition department and drive the development of its strategic growth agenda.
You may also like
Ingredients
Dsm-firmenich proposes Richard Ridinger as Chair as Thomas Leysen announces retirement
With current Chair of the Board of Directors, Thomas Leysen, stepping down, the fragrance and flavours company’s board has proposed Independent Director of dsm-firmenich, Richard Ridinger, as his successor
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Ingredients
Can Pentavitin take hyaluronic acid’s crown as the beloved skin care hydrator?
More beauty brands are infusing plant-derived moisturising ingredient, Pentavitin, into their formulations because it can bind moisture to the keratin in the skin for 72 hours without it evaporating, providing longer-term hydration. Beauty Writer Bethan King investigates
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Ingredients
FDA adds bemotrizinol to list of permitted sunscreen ingredients in the US, its first update in 20 years
Bemotrizinol, which is widely used in Europe, has been added to the FDA’s list of permitted sunscreen active ingredients. It is said to protect against both ultraviolet A and B rays and has low levels of absorption through the skin into the body
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.